Naproxen Sodium
Naproxen Sodium is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Naproxen Sodium; Generic name: NAPROXEN SODIUM; Manufacturer: PD-Rx Pharmaceuticals, Inc..
| Brand name | Naproxen Sodium |
|---|---|
| Generic name | NAPROXEN SODIUM |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis Naproxen sodium tablets are also indicated for: the relief of the signs and symptoms of: tendonitis bursitis acute gout the management of: pain primary dysmenorrhea Naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • polyarticular juvenile idiopathic arthritis Naproxen sodium tablets are also indicated for: the r |
| Dosage | 2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. (2.1) Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis Naproxen sodium tablets 275 mg 550 mg twice daily The dose may be adjusted up or down depending on the clinical response of the patient. In patients who tolerate lower doses well, the dose may be increased to naproxen 1500 mg/day for up to 6 months. Polyarticular Juvenile Idiopathic Arthritis N |
| Warnings | WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS Cardiovascular Thrombotic Events Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [ see Warnings and Precautions (5.1) ]. Naproxen sodium tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surge |
| Active ingredient(s) | NAPROXEN SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=145cdcc0-9bd5-4a0e-81fc-11a24d181980 |